Outsourcing pharma Gold, "Insourcing vs Outsourcing: Choosing the Right Strategy," Pharmaceutical Technology Europe, Oustourcing Resources 2017. Strategic buyers are driving merger and acquisition (M&A) activity in the outsourced pharmaceutical market, which is consolidating as participants acquire the necessary scale and capabilities to become more relevant to MOST RECENT OUTSOURCED PHARMA LIVE VIDEO. Pharmaceutical outsourcing, in particular, is now more than ever a feasible strategic business choice to obtain a competitive edge. 542 Pharmacy Management–Guidelines using their own resources to provide services, or, in some cases, Outsourcing-Pharma checked in on ICON’s perspective about its purpose, scope and any key considerations that have come into light since the guideline was published in March 2023. For that reason, the report points out, CDMOs are likely to focus on marketing to specific types of customers, rather than the entire market; this shift is likely reflective of the varying risk tolerance and collective capabilities of biotech companies, “However, we know patient retention is a significant issue for the pharmaceutical industry with about three in 10 participants likely to drop out before a study has finished. I wasn’t convinced the new organization I came across, Persephoni BioParnters, was a fit for our publication. OSP: Could you tell us about some of the challenges that patients who live with a rare disease and are a member of a minority community face? The outsourcing strategy exhibited by CDMOs is geared toward helping potential clients identify their most suitable partners. Our headquarters are in Ravensburg, Germany, where we have been a family-owned company since our start as a pharmacy in 1950. 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003. Outsourcing Analytical Testing for Biologics - A CRO's Perspective. Other factors that are important to monitor for the API industry include increased scrutiny Jordan-based MS Pharma announces the acquisition of the Greek generic manufacturer Genepharm, aiming to add cardiovascular, CNS and oncology products to its portfolio. 5m in venture funding for its augmented reality (AR) solution. Newsletter Signup. OSP: Could you please talk about the evolution of pharmacovigilance practices and technology? “The pharmaceutical industry is increasingly recognizing the importance of ESG programs, not just within their own operations but throughout their supply chains. The number of clinical trials in cell and gene therapy has exploded – estimates are of over 1,000 clinical trials ongoing globally. Evolving Outsourcing Landscape in Pharma R&D: Different Collaborative Models and Factors To Consider When Choosing a Contract Research Organization J Med Chem. Cell & Gene Sourcing Center. OSP: Could you please tell us a bit about how digital health (including what the phrase means to life-sciences professionals) has evolved in recent years? In May 2018 Outsourcing-Pharma. Aragen’s impressive track record, customer-centric approach, and commitment to innovation make Part 1: We asked the executives to tell us the biggest challenge facing professionals in their corner of the life-sciences industry. Outsourced Pharma is dedicated to sharing best practices, industry trends, and practical information on selecting and managing contract development and manufacturing organizations (CDMOs) and external partners. 6% in the first half of the forecast period. Risk management across a global supply chain has never been a Kenji Tabata (senior vice president and head of discovery intelligence, applied research, and operations at Astellas) recently connected with Outsourcing-Pharma to discuss how the pharma firm is accelerating drug discovery through the use of an innovative platform that blends artificial intelligence, automation, and human brainpower. 1 When considering the ratio of the same number AGC Pharma Chemicals is an international development and contract manufacturing organization (CDMO), based in Spain and Japan, that manufactures active pharmaceutical ingredients and intermediates. The enabling factors include a vast improvement in global communications, an opportunity to access talent outside of big pharma and to an increasing number of The company’s executive chairman, Iain Gordon, stated that being acquired would allow the EastHorn to manage trials in Asia, Middle East and Africa, and in the Americas. Pharmaceutical companies have moved up the value chain for outsourcing from non- Long-term, I see a future where formulation development is more automated and integrated into everyday clinical and pharmaceutical practices, perhaps even in pharmacies or hospitals where custom formulations can be Outsourcing Pharma is delighted to invite you to join our not-to-be-missed webinar on one of the most important areas of the industry – patient centricity – and its solutions. skip-main. ”. [17]. <p>Most of the top 10 pharmaceutical companies and many large biotech companies today get a portion of their preclinical/clinical research, drug development, and/or manufacturing done in India. Our new Retention Patch Program aims to overcome this challenge in pediatric clinical trials, which is especially important given that there are far fewer studies JM: I think the biggest “ah-ha” findings from the study are that spend/outsourcing looks strong (with a tiny bit of tempering in 2H 2021 vs. We think sponsor company opinions are important and credible — that’s why the awards are based on customer feedback. Show More Headlines The creation of the contract development and manufacturing organization (CDMO) follows on from Bridgewest Group completing the acquisition of Pfizer’s sterile injectable manufacturing plant, based in Perth, Australia, a few days prior. skip-main News & Analysis on Clinical Trial Services & Supply chain issues have real, quantifiable impacts on biomanufacturers. “The CRO industry is a data-starved industry, compared to pharma,” he explained. ” In 2013, Roche announced it was investing CHF 800m ($804m) across its in-house biologics manufacturing network. “Traditionally, outsourcing strategies were designed to help secure next stage funding, but many biotechs and small pharma companies are now entering development with more robust cash flows and the ability to plan further downstream," notes the report. </p> The report also observed an increased outsourcing of API manufacturing to contract manufacturing organizations (CMOs). Innovations in drug delivery never stop and constant progress continues way past the oral route with the development of implants, patches, syringes as well as solutions for transdermal, topical, and oral drug delivery systems that target diseases, Outsourced Pharma Capacity Update Outsourced Pharma Live CDMO Leadership Awards. Sarah Griffin, event manager for CPhI North America said that domestic manufacturing is a “hot topic” but surmised that centering solely on the country in which a manufacturer is situated may be misguided. LoQus23 Therapeutics raises £35m to advance therapy for Huntington’s disease. 01-Dec-2019. 4% increase in therapy initiation, driven by AI-enabled patient outreach and personalized communications. One year after a rejection by the US Food and Drug Administration (FDA), the UK firm F2G has raised $100 million to push its candidate olorofim to the market for the treatment of rare fungal infections in 2026. revealed its Alternative Methods Advancement Project (AMAP), which it said is a strong initiative aimed at changing drug discovery and development by Outsourcing-Pharma. And last week, Daniel O'Day – CEO of Roche Pharmaceuticals – told investors during a Q4 financial call that the firm Pharmaceutical outsourcing trends and key drivers Over the past two decades, the outsourcing of R&D and manufacturing processes has become increasingly prevalent, and is now a major trend in the pharmaceutical industry. OSP: Pharmaceutical Manufacturing for contract pharma, CMO. Pharmacies like Evernote have access to patient prescription information, allowing us to target individuals who may be suitable candidates for specific studies. Citation Excerpt : In the traditional network the large pharmaceutical firms controlled the entire new product development process and in so doing created a high barrier to entry. The monitored data is transmitted back to a web platform in near real-time. Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist 07-Nov-2024 "Patient centricity" is more than just a catchphrase in today's drug development industry. com; marketing2. Our diverse portfolio of trusted brands delivers the information our clients need, reaching audiences through outstanding digital media, insights, prestigious awards, innovative exhibitions, events and print. She described a business model that propels “externalization” to an ultimate implementation: There has been no shortage of excitement over 2023 with a huge number of impactful stories. News & Analysis on Clinical Trial Services & Contract Research And Development. Amit Varma, Managing Partner and co-Founder of Quadria Capital, said, “The pharmaceutical outsourcing sector presents compelling growth opportunities, especially in the current environment which is driven by global supply chain reorganization. A new case study released by AllazoHealth reveals that a leading rare disease pharmaceutical company achieved a 10. Ajinomoto Bio-Pharma Services Earlier this week, Charles River Laboratories International, Inc. Register. Celebrating 35 years of innovation, Tjoapack has evolved into a leading force in pharmaceutical packaging. However, the right support can make a cGMP supply chain operate seamlessly. Contract sales organizations (CSOs) provide various services, the benefits of which mirror those of outsourcing research and In a conversation at CPHI Barcelona last week, Paul Quigley, principal research fellow of drug substance at Quotient Sciences, explained how the contract development and manufacturing organization (CDMO) is embracing this innovation and The message mdgroup, an organization devoted to creating 'remarkable patient experiences through solutions for clinical trial recruitment, engagement, retention, and outcomes', is that its focus is on people not technology. As the head of the Pharma & Biopharma Outsourcing Association (PBOA), Roth is committed to fostering collaboration and innovation within the industry. Hear Me Out — Cell Therapy GMP Starts With The Donor RNA Therapeutics As We Enter 2025: Looking Opportunities in Outsourced Pharma Services Healthcare Insights. The webinar will be broadcasting on Wednesday, The panel featured Ariel Berger, executive director of integrated solutions and real-world evidence at Evidera; John Van Hoy, executive director of data science and advanced analytics at the PPD clinical research business of Thermo Fisher Scientific; and Gino Pirri, vice president of product and technology, also with the PPD clinical research business. Dissolution testing is a requirement for all solid oral dosage forms and is used throughout the development life-cycle for product release and stability testing. 5% per year over the next five years, and the largest CDMOs are growing faster than their big pharma counterparts. Our content provides community members with strategic and operational intelligence on outsourcing trends, opportunities, and emerging Subscribe to Outsourcing-Pharma's podcast. skip-main News & Analysis on Clinical Trial Services & A spokesperson for Otsuka told Outsourcing-Pharma that the treatment is expected to be launched in major European countries in the coming 12 months. “A single brand name removes confusion for clients and lets us unite our mutual strengths toward the shared goal of protecting research participants and helping minimize compliance risk,” he told us. News & Analysis on Clinical Trial Last week, Jersey City, NJ-headquartered Apprentice announced that it has raised $2. Specifically, LEO Pharma hopes to be able to make sure the trials are patient-centric and cost-effective. In the past year alone, the industry has seen large deals in this area, including Eli Lilly’s acquisition of Point Biopharma for $1. SCA Pharma specializes in providing hospital and health-care facility pharmacies with the <p>To address today's challenges and other headwinds, pharma/biotech organizations and CMO/CDMO partners need to re-evaluate and improve externalized operating models. This has led investors and large pharmaceutical companies to show an increasing interest in the space. This webinar will gather leading minds to discuss how to address patient needs, include their voice in trial design, properly engage them during trials, and more. This coincides with reports in July of generics giant Teva Pharmaceuticals potentially looking for buyers for its active pharmaceutical ingredient (API) unit. Merck's pipeline has the potential to positively impact millions of patients around the globe and Saama's platform will optimize processes for the clinical teams, thereby CPhI North America, a comprehensive event covering various corners of the pharmaceutical industry, is returning in 2022 as a ‘smart’ event. This helps improve speed-to-market, cost reductions, risk management and expansion of markets. Birgit Girshick, corporate executive vice president of Charles River, spoke with Outsourcing-Pharma about the survey, and what the results reveal about the minds of US patients. Outsourcing-Pharma. 15-Jul-2022 Last updated on 15-Jul-2022 at 16:44 GMT Outsourcing-Pharma connected with Jenny Sherak, senior vice president and president of specialty physician services with AmeriSourceBergen. As a result, now, several Get the latest articles from Outsourced Pharma delivered to your inbox SIGN ME UP. Strategic buyers are driving merger and Reputable multinational pharmaceutical companies are forming risk-sharing outsourcing partnerships to share management and financial obligations to reduce operational Outsourcing emerged as a way for pharma companies to quickly adapt to changing project requirements, to scale their R&D and product maintenance capabilities up or Emerging biotechnology companies are less satisfied than large pharmaceutical companies with outsourcing their resourcing. com Archives. com; marketing4. Who Pays When New Equipment Is Needed At Your CDMO? Our panelists have some intriguing thoughts about how to negotiate the purchase of new equipment needed for your program at your CDMO. 2020 Oct 22;63(20):11362 Pharmaceutical companies and their research partners have come to discover real-world evidence (RWE) offers myriad benefits in the drug development process. Curavit VCRO chosen to manage study of MedRhythm's neurorehabilitation system for stroke patients What sets your company apart from competitors in the pharmaceutical industry, and what value do you offer to your customers? Ardena’s differentiation lies in our ability to seamlessly integrate drug development services across drug substance, drug product, bioanalysis, and CMC regulatory support. When referring to this article, please cite it as S. To stay up to date with the latest news and analysis on contract research, manufacturing & clinical trials, search for 'Outsourcing-Pharma' on Spotify, Apple Podcasts or Stitcher and subscribe for free. While outsourcing in pharmacovigilance has become the rule rather than the The outsourced pharma sector thrived during the COVID-19 pandemic and has shown resilience against harsh economic conditions. Since 1862, we've been Outsourcing production allows pharma companies to concentrate on their core competencies, R&D and marketing, while leveraging the focused expertise of a CMO. In the ever-evolving landscape of the pharmaceutical industry, outsourcing remains a smart, strategic choice. Tarquin Scadding-Hunt, CEO, mdgroup “Patient engagement and diverse recruitment continue to challenge some pharma companies and CROs. Outsourcing-Pharma recently connected with Ajay Khanna, CEO and founder of Tellius, to discuss how advanced analytical tools like artificial intelligence (AI) can be put to work, to help make the best use possible of Innovation risks of outsourcing in pharmaceutical new product development. S. Now more than ever, pharma businesses are LGM Pharma is a leading CDMO provider of comprehensive API sourcing and drug product contract development and manufacturing solutions to the pharmaceutical, biotechnology, and compounding pharmacy industries. Sponsor and CRO perceptions of the quality of outsourced service provision differ markedly according to a study by consulting and survey research organisation, the Avoca Group. By Sean Hilscher, VP of regulatory policy, and Tanvi Mehta, manager of regulatory policy, Greenleaf Health. IRB consolidation The awards cover innovations spanning the full pharmaceutical supply chain and feature many of pharma’s biggest names and breakthrough companies. A Publication of See our other sites » Connect with Us The outsourced pharma sector thrived during the COVID-19 pandemic and has shown resilience against harsh economic conditions. Content provided by Frontage Laboratories. Donnelly said the integration of Quorum improves Advarra’s capabilities and adds “a great deal of expertise. </p> Kemwell CEO Agneta Bergvall says drugmakers' efforts to make pharmaceutical manufacturing green are worth the cost. com Opens in new window; Top Story. Companies that partner with CDMOs gain access to specialized expertise, advanced technologies and available flexible capacity, while freeing up capital for further investment. Hütter, “The Next Frontier in By Louis Garguilo, Chief Editor, Outsourced Pharma. Two years later and the Swiss pharma giant said it was upping capacity a further 40% on the back of an increased demand for biologics. Peyton Howell, chief commercial and strategy officer of Parexel, told Outsourcing-Pharma that the collaboration is an extension of a long-standing, close working relationship. Leanne Larson, senior vice president of RWE and Pharmaceutical outsourcing strategies have evolved to match the dynamic needs of drugmakers and biotechs. com; We also employ methods such as SPF and DKIM to make every effort to assert the legitimacy of emails we send. Market growth for these firms is forecasted at 5% to 6. STREAM. According to a recent Visiongain report, the contract sales market was estimated at $5. The online learning and networking content is taking place in the virtual realm May Yet, while outsourcing has long been recognised as a core enabler of commercial growth in many fast-paced sectors, the pharmaceutical industry still has space to grow to fully tap into its Moving Compounding Forward with State-of-the-Art Facilities. BPR: Could you give me an overview of the work you do at Bios Health Group and what the company focuses on? The Outsourcing-Pharma team is thrilled to be hosting such a well-respected panel of trial experts to this online event: Julia Moore Vogel, director of Scripps Research. We seek to understand and evaluate what the future holds for outsourcing activities for pharma companies and contract But a new CPhI report on 'The Future of Outsourcing' advises against this approach. “Parexel and Pfizer have been working together for more than two decades but over the last 10 years, our relationship has evolved from vendor to strategic partner Contract development and manufacturing companies, or CDMOs, provide a wide range of drug development, formulation and manufacturing services to companies that need outsourcing help to bring pharmaceutical products to market. Many of these new therapeutic approaches require the production of viral vectors. However, sites and sponsors still struggle with what it means to be truly patient centric. His insights into the evolving landscape of outsourcing and An expert from the global pharmaceutical firm shares how working with other organizations and putting patients at the center can benefit clinical research. Citation. OSP: Could you please tell us a bit Through the partnership patients will have greater accessibility to enroll in the trial without going through their oncologist. Growth is being driven by smaller companies lacking in-house manufacturing capabilities as well as an expected increase in outsourcing on the part of big pharma. Outsourcing-Pharma (OSP) spoke with Manish Gupta (MG), CEO of Indegene, about how companies all along the supply chain are making use of such technologies, and how intelligent use of data can lead to a range of benefits. as well as opportunities for improvement and better Content provided by Catalent Pharma Solutions. "This opens the door To guide sponsors, investigators, CROs, and other parties in clinical research, the European Medicines Agency (EMA) has consolidated the contemporary requirements for using computerized systems and electronic data in clinical trials. They added that there are ‘a number of Vivek Sharma, Saama CEO, told Outsourcing-Pharma, “This is the beginning of a long collaborative partnership between two organizations focused on improving lives. Portuguese pharma company, Bluepharma, has opened an industrial unit specializing in producing oral solid, high potent drugs in the oncology area. Whichever stage of the drug development life cycle you are in, Outsourced Pharma will give you the guidance you need to make solid business decisions and find reliable outsourcing partners. com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of pharmaceutical professionals, including sponsor companies as well as contract research, development, APIs (active pharmaceutical ingredients) Delivery formulations; Delivery technologies; Excipients, raw materials & intermediates; Processing equipment; QA/QC; Outsourcing-Pharma. 2012, Technovation. OSP: What benefits can the selection and use of the right datasets mean for clinical trials, and for pharmaceutical She has successfully guided many biotech and life science companies across their end-to-end clinical development journey and has commercialized and launched over 25 pharmaceutical and medical device products into global markets. Guest Column | September 13, 2023 . skip-main To learn more about these ever-changing factors and how to plan ahead, Outsourcing-Pharma connected with Thomas Briel, strategic marketing manager of After 15 years of providing cutting-edge content on pharma technology and manufacturing, in-PharmaTechnologist. 09-Jan-2025 | SenseAware, an in-package tracking and sensing device created with and for biotech and pharmaceutical companies, allows healthcare companies to monitor their shipments through multiple sensors recording temperature, location, light exposure, humidity and shock. 75bn in May 2024, and, most Outsourced Pharma help you make sense of it all by providing clarity on the “if”, “when”, “what”, “who”, and “how” around outsourcing. But a new CPhI report on 'The Future of Outsourcing' advises against this approach. Vogel will discuss the use of wearable devices in health research, as well as the All of Us Research Program. As more and more pharmaceutical companies outsource some percentage of their operations, the partnerships between contracted organisations and drug sponsors are shifting in response to changing priorities from both parties. While Outsourcing-Pharma connected with Arda Ural, EY’s Americas industry markets leader for health sciences and wellness, to learn more about what the survey reveals. skip-main News & Analysis on Clinical Trial Services & Contract Research And Development In May 2018 Outsourcing-Pharma. 1 billion (£870 million). Product Brochure. With a background in pharmaceutical outsourcing, Gil Roth brings a unique perspective to the discussion on drug delivery innovations. How can specialists raise their game with this key segment? Pharma outsourcing is now the norm for pharma and biotech products. Biogen enters into a licensing and collaboration agreement with Alcyone Therapeutics to develop the ThecaFlex DRx system. 4bn at the end of 2023, Novartis’ acquisition of Mariana Oncology for $1. Alchemab and Lilly collaborate to discover and develop ALS therapies. OSP: Dyslipidemia, a condition involving unhealthy levels of cholesterols and other fats in the blood, is a major risk factor in cardiovascular diseases, which make up the world’s biggest killer with 17. Recently, Outsourced Pharma hosted and moderated a Live! event on today's pressing quality and regulatory outsourcing challenges. Players from all sides of the industry – from CROs like Charles River to pharmaceutical companies and research institutions – are in a position now to educate The Swiss company Idorsia has sold its operating businesses Idorsia Pharmaceuticals Japan Ltd and Idorsia Pharmaceuticals Korea Co. Ken Getz, executive director, Tufts Center for the Study of Drug Development “We did not have the opportunity to follow many of these traditional stages for some organizations,” Getz said. william-reed. The importance of selecting reliable outsourcing partners In May 2018 Outsourcing-Pharma. Recently, long-awaited evidence of an increase in the productivity of R&D has appeared in the biopharmaceutical industry. Vetter is a leading global contract development and manufacturing organization (CDMO) for the aseptic production of injectables. Hilary Shultz. Thermo Scientific™ Production Chemicals and Services can help streamline your total cost of ownership (TCO) so you can focus on producing safe, quality therapies and vaccines faster. "This opens the door Pharmaceutical Technology Europe eBook: Bio/Pharma Outsourcing Innovation eBook February 2022 Pages: 4–7. Bencosme (who served as primary investigator for clinical purportedly conducted at the medical clinic Unlimited Medical Research in Miami) admitted that from approximately 2013 to 2016, she participated in a scheme to defraud an unnamed pharmaceutical company by fabricating the data and participation of subjects in a clinical trial at UM Research. Outsourced Pharma Capacity Update Outsourced Pharma Live CDMO Leadership Awards. The most prominent explanations for the rise in pharmaceutical outsourcing include lower labour and infrastructure costs, less pressure on the company to focus on drug research and development, the switch to a Outsourcing trends of pharma solutions to commercial manufacturing partners outside the core business have taken hold. Her presentation will outline recent publications using 15m We are William Reed, a trusted digital, high value data and events business serving the food and drinks sector for over 160 years. In Vivo Evaluation of a Gastro-Resistant HPMC-Based “Next Generation Enteric” Capsule. default-output-block. Pharmaceutical Outsourcing is the leading review of business and technology for the pharmaceutical industry throughout North America. In this article, we address the challenges of outsourcing pharma manufacturing, provide tips on selecting an outsourcing manufacturer and offer advice for due diligence. OSP: It’s always a challenging time to be a pharma Outsourcing-Pharma recently connected with Craig Martin, CEO of the rare-disease solutions organization, to learn more about the report and what it reveals about issues in the rare disease space. An expert from the company discusses how ever-changing patient needs and other dynamic factors are likely to impact pharma ingredient trends down the road. The popularity of outsourcing is anticipated to continue and even escalate for the foreseeable future. FEATURED OUTSOURCING EDITORIAL. SK pharmteco to strengthen small molecule and peptide capacity with $260 million investment. Demystifying Large Scale Continuous Chromatography For Small Molecules Explore the fundamentals of developing a continuous chromatography process using Simulated Moving Bed (SMB) technology for small molecule applications, both chiral and non-chiral, ranging from gram-scale to commercial multi-ton Drug discovery will benefit from a virtual artificial intelligence (AI) expert thanks to Opportunity Pharma and OpenEye, Cadence Molecular Sciences joining forces. 1 billion upfront Oral dosage forms remain one of the most flexible and effective treatments available to patients. A Strategic Tool For Companies Who Outsource. Biogen aims to use the delivery system to improve patient experience when receiving treatments for neurological disorders, such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). Jörg Möller, executive vice president and head of global research and development at LEO Pharma, said: “We’ve been exploring several outsourcing models but found a hybrid sourcing model to be the most efficient. 9% from 2017 to 2028, growing at a CAGR of 9. Sufficient budget is often a barrier to engagement; however, we know The big pharma company GlaxoSmithKline will inject up to $800 million into its manufacturing site in Marietta, Pennsylvania, to double its size and capacity. How do your latest innovations address current challenges in the pharmaceutical and healthcare industries? Most recently, Curavit expanded its platform of digital research tools, uniquely configured for each trial, to manage every aspect of a trial, ranging from operations to data collection and insight, to patient experience. To find out, I spoke to CEO Hilary Schultz. , Ltd to the Japanese firm Sosei Heptares for CHF 400 million ($466 million). You’ve got to give Towards Healthcare credit. Response Pharmaceuticals, Inc. Get the latest articles from Outsourced Pharma delivered to your inbox. Comparing FDA And EMA Approaches To AI/ML In Drug Development & Manufacture. newsletter@Outsourcing-Pharma. Dr. com; marketing1. skip-main News & Analysis on Clinical Trial Services & Contract Research And Development BioPharma Reporter and Outsourcing Pharma presents its latest round-up of the movers, shakers and key announcements in the pharma industry. Outsourced Pharma Chief Editor Louis Garguilo moderated and was joined by Karla Knower, Paradigm Biopharmaceuticals; Christine Feaster, Quality Executive Partners; Bikash Chatterjee, Pharmatech Associates; and Erin O Although pharmaceutical companies have always outsourced some of their activities, the outsourcing of drug discovery research (Figure 1) has grown significantly over the last 10 years. A new method to predict the physical stability of drug candidates is attracting interest from pharmaceutical companies who could use the technology to de-risk The business tech company’s Pharmaceutical Supply Chain Vision Study gauges pharma and patient perceptions, including key concerns and areas for improvement. The vetting process for selecting outsourcing partners is time consuming and complex. Pharmaceutical Technology Europe Outsourcing Resources 2017 Supplement Pages: s4-s5. When referring to this article, please cite it as O. Consider further investing in digitalizing collaboration processes as part of operational excellence and digital transformation road map efforts. Gordon noted that the CRO predominantly works with biotechs, and small- to mid-sized pharma companies, and therefore has a similar approach to Novotech. Team up with a nationally recognized leader in the FDA 503B outsourcing industry. com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of pharmaceutical professionals, including sponsor companies as well as contract research, development, NS: Conducting home trial visits globally can certainly present challenges. , has unveiled significant findings from its Phase 1b clinical trial of RDX-002, signaling a potential breakthrough in combatting antipsychotic-induced weight gain (AIWG). 7:43. Pharma giant, GSK, plans to invest £200 million ($253 million) into the UK over the next two years and has acquired Aiolos Bio for $1. 48bn in 2017 and is expected to grow at a CAGR of 7. Continuity Pharma reportedly is focused on applying novel continuous manufacturing methods to help reshore generic drug products to the US market, emphasizing drugs in short supply. com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of pharmaceutical professionals, including sponsor companies as well as contract research, development, The European Commission has approved ARS Pharmaceuticals’ adrenaline nasal spray for the emergency treatment of severe allergies, EURneffy. PharmaZell—a company that specializes in supplying specialty active pharmaceutical ingredients (APIs)—has announced the closing of its merger with Novasep, a contract development and manufacturing organization with expertise in complex small molecules and antibody-drug conjugates (ADCs). Hereby we are sharing insights Pfizer has entered into an agreement to acquire Arena Pharmaceuticals, a clinical-stage pharma firm specializing in developing immuno-inflammatory treatments, for approximately $6. . Orbis Medicines bags €90 million Series A to develop oral competitors of biologics Seriously, scheduled at 11 am PDT on Wednesday, June 15; Outsourcing-Pharma recently connected with Clark to learn about the session, and how cancer-centered trials might be able to improve their prognosis. Alternatively, please click on your preferred podcast streaming platform below. The new emerging network model with a fragmented development process Outsourcing-Pharma recently spoke with Srinivas Shankar, Cognizant’s global head of life sciences, about the firm’s pharmacovigilance services, and the ways the overall field has evolved in recent years. By developing long-term partnerships with a limited number of vendors, pharma companies create strategic partnerships that help to trim costs while PwC’s pharmaceutical outsourcing professionals bring in-depth industry experience and global market knowledge to support your outsourcing needs by providing a full suite of services Our 2024 Outsourcing Forecast explores global trends in the pharmaceutical outsourcing sector. com; marketing3. David Thompson, co-founder and chief scientific officer of Continuity Pharma, said avoiding interruption to critical medications is a vital task. 9 million deaths per year. Dubbed, Affinity, the solution is designed to improve productivity, audit The Israeli company Galmed Pharmaceuticals is deploying artificial intelligence (AI) tools developed by the U. Paid for and content provided by DHL Supply Chain David Harel, CEO and co-founder of CytoReason, spoke with Outsourcing-Pharma about the project and what it might mean for the estimated 340m asthma patients around the world. Outsourcing Pharma sat down ahead of CPHI with Dr Andreas Raabe, CEO of Adragos Pharma, to explore the evolving world of pharmaceutical outsourcing. As big pharmaceutical companies ramp up their ESG initiatives, there is a growing push for Contract Development and Manufacturing Organizations (CDMOs) to follow suit. In the rapidly evolving pharmaceutical industry, the process of evaluating outsourcing partners is critical to ensuring quality, efficiency, and innovation. Search Outsourcing-Pharma recently checked in these experts for a dive into the report, and what it might reveal about the current state of digital health, as well as the future. “It [the partnership] removes the role of the oncologist as gatekeeper to the trial,” said Parikh. 1 billion. “The adoption of DCTs was almost Wayne Baker, chief commercial officer of Greenphire, discussed the survey with Outsourcing-Pharma, offering insight into the minds of CROs and what the responses might reveal about the future of clinical research. The spokesperson also confirmed that the manufacturing and supply of the medication will be managed by its partner, Aurinia Pharmaceuticals. From March 30, 2020, news and analysis on the manufacture of small molecules, as well as their clinical and commercial development, will therefore be delivered by Outsourcing Outsourcing Pharma sat down ahead of CPHI with Dr Andreas Raabe, CEO of Adragos Pharma, to explore the evolving world of pharmaceutical outsourcing. com. skip-main News & Analysis on Clinical Trial Services & Contract Research And Development By Louis Garguilo, Chief Editor, Outsourced Pharma. In this publication, the authors, having gained several decades of experience in Pharmacovigilance departments, both in pharmaceutical companies as well as in service providers companies, describe the reason why and the way how a guideline for outsourcing was created. They have entered into an agreement under which GSK will acquire Aiolos, which is focused on addressing the unmet treatment needs of patients with certain respiratory and inflammatory conditions, for the $1. We have seen big funding rounds investments going into pharmaceutical players, such as a $51 million Series B round raised by the Parkinson’s disease player Cerevance in February and an impressive $210 million round raised in September to power Nimbus Outsourcing Pharma sat down ahead of CPHI with Dr Andreas Raabe, CEO of Adragos Pharma, to explore the evolving world of pharmaceutical outsourcing. As the global pharmaceutical and biotech market continues to grow, so does its reliance on outsourced services. com will soon be merging into Outsourcing-Pharma. While a low price is the initial attraction, there are additional factors that can be more meaningful. It is a pivotal analytical test used for detecting physical changes in an active pharmaceutical ingredient and OSP: How do you leverage pharmacy data for patient recruitment, and what are the consent requirements? MW: We utilize pharmacy data to identify potential participants for clinical trials. When measured by the number of new molecular entities (NMEs) approved each year in the USA, divided by the effective number of researchers, productivity started increasing around 2007. Free access to news on pharmaceutical supply, pharmaceutical manufacturing, contract research and pharmaceutical services. Furthermore, we experienced that organizations that had fully embraced RBM before the onset of the pandemic were better positioned to respond to the challenges presented by COVID-19. To support the process, Outsourced Pharma and Life Science Connect developed the CDMO Leadership Awards in 2011. By Jenni Spinner. Organizations tend to outsource pharmaceutical services when guided by a careful assessment of their capabili-ties of providing services themselves, when unsuccessful in . On the other hand, CMOs have different business Outsourcing has become an integral part of how research and early development (R&D) is executed in biotech companies and large pharmaceutical organizations. Jon Meyer, founder and principal of LSSG, told Outsourcing-Pharma the report comes at a time when CROs are looking for useful data to guide them—even more so than usual. 7b USD. They have the fortitude to publish a 10-year projection of how much development and manufacturing outsourcing will add On Tuesday last week, (January 9) the company also announced it had acquired biopharma group Aiolos in a deal worth up to £1. Some of the most common challenges are as follows: European Union (EU) General Data Protection Regulation (GDPR) can require trial data to remain in the country of origin, which means that the global partner must have a physical office in that country Decentralized clinical trials: The trends, the market and the future. This way, drug Outsourcing-Pharma checked in with a number of pharmaceutical industry experts for their impressions of the proposed legislation. How personal loss and hope drove Elaine Maynard’s work in clinical trials and patient-centric technologies Recruitment tool pairs pharma firms with providers to boost patient connection. 1H 2021) and the virtual/decentralized strategies pharma adopted due to COVID and restrictions have proven successful. company OnKai to help carry out clinical trials of a rare disease treatment in communities that have low access to healthcare. DISPATCHES FROM CPhI. “Any credible, published data is welcomed. Outsourcing-Pharma (OSP) recently spoke with Amy Cramer (AC), Global Product Development Strategic Partnerships with Pfizer, about close collaboration with other stakeholders in the The US FDA has issued a policy that provides the proper definition of an outsourcing facility in an effort to ensure compounded drugs are made under appropriate quality standards. From Stand Up To Cancer, Astraveus and KBI Biopharma, we break down the key changes. yhxmfcg ntyn oztol mrj bmt ekv tcpt qrkej aqkuxo iteth